Onderneming Horizon Pharma Inc Nasdaq
Aandelen
US44047T1097
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 01-06-08 |
Aaron Cox
DFI | Director of Finance/CFO | 41 | 01-04-16 |
Karin Rosen
CTO | Chief Tech/Sci/R&D Officer | 57 | 02-11-20 |
Vikram Karnani
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-07-14 |
Chief Tech/Sci/R&D Officer | 66 | 01-10-16 | |
Jeffrey Sherman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-06-09 |
Keli Walbert
SAM | Sales & Marketing | - | 01-01-18 |
Comptroller/Controller/Auditor | 45 | 01-02-15 | |
David Caraher
SEC | Corporate Secretary | - | - |
Jane Gonnerman
HRO | Human Resources Officer | - | 01-10-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 01-06-08 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 229 378 934 | 226 691 767 ( 98,83 %) | 384 366 ( 0,1676 %) | 98,83 % |
Bedrijfsgegevens
Horizon Therapeutics Plc
70 St. Stephen's Green
4, Dublin
+353 1 772 2100
http://www.horizontherapeutics.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Horizon Pharma Treasury Ltd.
|
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,06% | 682 mld. | |
+30,35% | 586 mld. | |
-3,42% | 364 mld. | |
+18,02% | 327 mld. | |
+4,27% | 285 mld. | |
+15,53% | 240 mld. | |
+10,16% | 209 mld. | |
-8,14% | 203 mld. | |
+8,12% | 165 mld. |
- Beurs
- Aandelen
- Koers HZNP
- Koers
- Onderneming Horizon Pharma Inc